Budesonide treatment for microscopic colitis from immune checkpoint inhibitors

BACKGROUND: Immune checkpoint inhibitors (CPIs) are effective against a variety of malignancies but can be limited by inflammatory toxicities such as enterocolitis. Enterocolitis is typically treated with systemically active glucocorticoids. Endoscopy can stratify patients by the severity of mucosal...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughes, Michael S., Molina, Gabriel E., Chen, Steven T., Zheng, Hui, Deshpande, Vikram, Fadden, Riley, Sullivan, Ryan J., Dougan, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839080/
https://www.ncbi.nlm.nih.gov/pubmed/31699151
http://dx.doi.org/10.1186/s40425-019-0756-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839080/
https://www.ncbi.nlm.nih.gov/pubmed/31699151
http://dx.doi.org/10.1186/s40425-019-0756-0

Ejemplares similares